Moon-Hyuk Chi

Title: Moon-Hyuk Chi: Innovator in Sustained Release Formulations

Introduction

Moon-Hyuk Chi is a notable inventor based in Suwon, South Korea. He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of sustained release technologies. With a total of 2 patents, his work focuses on improving drug delivery systems to enhance patient outcomes.

Latest Patents

Chi's latest patents include a "Sustained release formulation for oral administration of HMG-CoA reductase inhibitor and method for the preparation thereof." This innovative formulation can be easily and economically prepared, maintaining a constant drug level in the blood by slowly releasing the HMG-CoA reductase inhibitor at a uniform rate for 24 hours. This sustained release formulation is particularly effective for lowering blood cholesterol and triglyceride levels. Another significant patent is the "Sustained release composition for oral administration of drugs." This composition comprises a drug, a mixture of sodium alginate and xanthan gum as a carrier, and a mixture of hydroxypropyl methylcellulose and propylene glycol alginate as a gel hydration accelerator. This formulation is capable of maintaining a constant drug level in the blood for 24 hours or more, following zero-order kinetics in drug release.

Career Highlights

Throughout his career, Moon-Hyuk Chi has worked with prominent companies in the pharmaceutical industry, including Hanmi Science Co., Ltd. and Hanmi Pharm. Co., Ltd. His experience in these organizations has contributed to his expertise in drug formulation and delivery systems.

Collaborations

Chi has collaborated with notable colleagues such as Jae-Kuk Ryu and Hong-Gi Yi. These partnerships have likely enhanced his research and development efforts in the field of sustained release formulations.

Conclusion

Moon-Hyuk Chi's innovative work in sustained release formulations has the potential to significantly impact the pharmaceutical industry. His patents reflect a commitment to improving drug delivery systems for better health outcomes.